Showing results (1431-1440 of 6,507) with videos related to
Sort By:
Pageof 651
Cancer Immunology, Immunotherapy : CII|December 18, 2025
Identification of HLA class II-restricted T cell receptors against shared PIK3CA mutations in patients with epithelial cancersS M Rafiqul Islam, Samantha Seitter, Maria Parkhurst, et al.Cancer Immunology, Immunotherapy : CII|December 18, 2025
Combined CD25-targeted near infrared photoimmunotherapy (NIR-PIT) and intratumor IL-15 enhance the effectiveness of anti-PD-1 immunotherapyMakoto Kano, Aki Furusawa, Hiroshi Fukushima, et al.Cancer Immunology, Immunotherapy : CII|December 18, 2025
Gut microbial metabolite butyrate boosts p53-expressing telomerase-specific oncolytic adenovirus efficacy by enhancing infectivity and activating MHC-I/cGAS-STINGMasaki Sakamoto, Shinji Kuroda, Tetsuya Katayama, et al.Cancer Immunology, Immunotherapy : CII|December 19, 2025
Exploration of the benefits and resistance mechanisms of immunotherapy based on PD-L1 expression, circulating tumor DNA and T-cell receptor profiles in advanced gastric cancerMiaomiao Gou, Niansong Qian, Yong Zhang, et al.Cancer Immunology, Immunotherapy : CII|December 23, 2025
Modeling anti-tumor immune responses using patient-derived melanoma organoidsKamila Kaminska, Bengt Phung, Jacob Karlström, et al.Cancer Immunology, Immunotherapy : CII|December 19, 2025
RERE-AS1 as a regulator of immune modulation and therapeutic response in breast cancerShaohui Jiang, Weijie He, Zhimin Li, et al.Cancer Immunology, Immunotherapy : CII|June 21, 2025
Immunological synapse formation as a key mechanism in T cell-dependent bispecific antibody-mediated immune activation and cytotoxicityRikuto Nakamura, Ryo Tsumura, Takahiro Anzai, et al.Cancer Immunology, Immunotherapy : CII|January 3, 2025
Identification of immune suppressor candidates utilizing comparative transcriptional profiling in histiocytic sarcomaJennifer A Lenz, Brandon Peng, Charles-Antoine Assenmacher, et al.Cancer Immunology, Immunotherapy : CII|January 3, 2025
Metastatic sites of baseline as predictors in recurrent or metastatic nasopharyngeal carinoma treated with PD-L1 inhibitor: a secondary analysis of multicenter, single-arm, phase II study (KL-A167)Yuantai Li, Yu Min, Zhigong Wei, et al.Cancer Immunology, Immunotherapy : CII|February 11, 2025
Neutrophil-induced pyroptosis promotes survival in patients with hepatoblastomaTingyi Fu, Jiquan Zhou, Liyuan Yang, et al.Pageof 651